Incidentally Detected Asymptomatic Perianal Abscess in an Adolescent during Crohn's Disease Diagnosis: Is Routine Pelvic Imaging Required in Korean Pediatric Patients at Diagnosis? |
Um, Soo Hyun
(Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine)
Lee, Sang Woo (Department of Pediatrics, School of Medicine, Kyungpook National University) Song, Ki Hwan (Department of Surgery, Goo Hospital) Lee, So Mi (Department of Radiology, School of Medicine, Kyungpook National University) Choe, Byung-Ho (Department of Pediatrics, School of Medicine, Kyungpook National University) Lee, Yoo Min (Department of Pediatrics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine) Kang, Ben (Department of Pediatrics, School of Medicine, Kyungpook National University) |
1 | Kang B, Lee Y, Lee K, Choi YO, Choe YH. Long-term outcomes after switching to CT-P13 in pediatric-onset inflammatory bowel disease: a single-center prospective observational study. Inflamm Bowel Dis 2018;24:607-16. DOI |
2 | Kang B, Choi SY, Choi YO, Kim MJ, Kim K, Lee JH, et al. Subtherapeutic infliximab trough levels and complete mucosal healing are associated with sustained clinical remission after infliximab cessation in paediatric-onset Crohn's disease patients treated with combined immunosuppressive therapy. J Crohns Colitis 2018;12:644-52. DOI |
3 | Duricova D, Fumery M, Annese V, Lakatos PL, Peyrin-Biroulet L, Gower-Rousseau C. The natural history of Crohn's disease in children: a review of population-based studies. Eur J Gastroenterol Hepatol 2017;29:125-34. DOI |
4 | Kang B, Kim JE, Jung JH, Choe JY, Kim MJ, Choe YH, et al. Korean children and adolescents with Crohn's disease are more likely to present with perianal fistulizing disease at diagnosis compared to their European counterparts. Pediatr Gastroenterol Hepatol Nutr 2020;23:49-62. DOI |
5 | Kang B, Choi SY, Choi YO, Lee SY, Baek SY, Sohn I, et al. Infliximab trough levels are associated with mucosal healing during maintenance treatment with infliximab in paediatric Crohn's disease. J Crohns Colitis 2019;13:189-97. DOI |
6 | Kim PH, Park SH, Jin K, Ye BD, Yoon YS, Lee JS, et al. Supplementary anal imaging by magnetic resonance enterography in patients with Crohn's disease not suspected of having perianal fistulas. Clin Gastroenterol Hepatol 2020;18:415-23.e4. DOI |
7 | Bouguen G, Levesque BG, Feagan BG, Kavanaugh A, Peyrin-Biroulet L, Colombel JF, et al. Treat to target: a proposed new paradigm for the management of Crohn's disease. Clin Gastroenterol Hepatol 2015;13:1042-50.e2. DOI |
8 | AlSabban Z, Carman N, Moineddin R, Lo RT, King SK, Langer JC, et al. Can MR enterography screen for perianal disease in pediatric inflammatory bowel disease? J Magn Reson Imaging 2018;47:1638-45. DOI |
9 | Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr 2015;169:1053-60. DOI |
10 | Hong SJ, Cho SM, Choe BH, Jang HJ, Choi KH, Kang B, et al. Characteristics and incidence trends for pediatric inflammatory bowel disease in Daegu-Kyungpook province in Korea: a multi-center study. J Korean Med Sci 2018;33:e132. DOI |
11 | Buchanan G, Halligan S, Williams A, Cohen CR, Tarroni D, Phillips RK, et al. Effect of MRI on clinical outcome of recurrent fistula-in-ano. Lancet 2002;360:1661-2. DOI |
12 | Sykora J, Pomahacova R, Kreslova M, Cvalinova D, Stych P, Schwarz J. Current global trends in the incidence of pediatric-onset inflammatory bowel disease. World J Gastroenterol 2018;24:2741-63. DOI |
13 | Roberts SE, Thorne K, Thapar N, Broekaert I, Benninga MA, Dolinsek J, et al. A systematic review and meta-analysis of paediatric inflammatory bowel disease incidence and prevalence across Europe. J Crohns Colitis 2020;14:1119-48. DOI |
14 | Adler J, Dong S, Eder SJ, Dombkowski KJ. ImproveCareNow Pediatric IBD Learning Health System. Perianal Crohn disease in a large multicenter pediatric collaborative. J Pediatr Gastroenterol Nutr 2017;64:e117-24. DOI |
15 | de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, et al. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013;19:378-85. DOI |
16 | Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. DOI |
17 | Maaser C, Sturm A, Vavricka SR, Kucharzik T, Fiorino G, Annese V, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis 2019;13:144-64. DOI |
18 | Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, et al. Clinical practice guideline for the medical management of perianal fistulizing Crohn's disease: the Toronto consensus. Inflamm Bowel Dis 2019;25:1-13. DOI |
19 | Kim S. Surgery in pediatric Crohn's Disease: indications, timing and post-operative management. Pediatr Gastroenterol Hepatol Nutr 2017;20:14-21. DOI |
20 | Arai K, Kunisaki R, Kakuta F, Hagiwara SI, Murakoshi T, Yanagi T, et al. Phenotypic characteristics of pediatric inflammatory bowel disease in Japan: results from a multicenter registry. Intest Res 2020;18:412-20. DOI |
21 | Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, et al. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig Dis Sci 2010;55:1989-95. DOI |
22 | Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clin Gastroenterol Hepatol 2018;16:190-7.e11. DOI |
23 | Kang B, Choi SY, Kim HS, Kim K, Lee YM, Choe YH. Mucosal healing in paediatric patients with moderate-to-severe luminal Crohn's disease under combined immunosuppression: escalation versus early treatment. J Crohns Colitis 2016;10:1279-86. DOI |
24 | Kang B, Choe YH. Early biologic treatment in pediatric Crohn's disease: catching the therapeutic window of opportunity in early disease by treat-to-target. Pediatr Gastroenterol Hepatol Nutr 2018;21:1-11. DOI |
![]() |